Topline Moderna and BioNTech shares both cratered to their lowest price in years Monday as the companies behind the most widely-circulated mRNA Covid-19 vaccines grapple with investor disappointment with crashing revenues. Moderna and BioNTech each suffered major stock losses Monday.LightRocket via Getty Images Key Facts BioNTech and Moderna’s stocks fell 8% and 6%, respectively, a
Moderna and BioNTech’s stocks hit new lows as investor disappointment with crashing revenues grows.
BioNTech’s sales fell 95% YoY last quarter, while Moderna’s revenues declined 93% YoY in Q2. Both companies have forecasted significantly lower Covid vaccine sales for this year.
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
